Zuoquan Xie

8PUBLICATIONS
17CO-AUTHORS
Biologically active moleculesGene and molecular therapyNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 23, 2024
Discovery of a non-nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect.

Xiyuan Wang, Zhengsheng Zhan, Zhen Wang

|Nov 18, 2024
Sodium oligomannate disrupts the adherence of Ribhigh bacteria to gut epithelia to block SAA-triggered Th1 inflammation in 5XFAD transgenic mice.

Xinyi Wang, Zuoquan Xie, Jie Yuan

|Nov 02, 2024
Integrated omics profiling reveals systemic dysregulation and potential biomarkers in the blood of patients with neuromyelitis optica spectrum disorders.

Zuoquan Xie, Qinming Zhou, Jin Hu

|Jul 31, 2024
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation.

Hangtian Yue, Hui Xu, Lanping Ma

|Jul 08, 2024
GV-971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities.

Xinying Yang, Zhongheng Zhangyi, Aisong Yu

|Jun 20, 2022
Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation.

Mengyan Du, Ting Yu, Qinjinge Zhan

Pageof 2

Frequent Collaborators

2 joint publications

Meiyu Geng

1 joint publications

Shu-Hai Lin

1 joint publications

Min Huang

1 joint publications

Hangtian Yue